1. Home
  2. SPH vs XERS Comparison

SPH vs XERS Comparison

Compare SPH & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Suburban Propane Partners L.P.

SPH

Suburban Propane Partners L.P.

HOLD

Current Price

$17.56

Market Cap

1.2B

ML Signal

HOLD

XERS

Xeris Biopharma Holdings Inc.

HOLD

Current Price

$8.85

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPH
XERS
Founded
1945
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
SPH
XERS
Price
$17.56
$8.85
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$10.83
AVG Volume (30 Days)
200.6K
1.6M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
6.63%
N/A
EPS Growth
42.11
100.00
EPS
2.48
N/A
Revenue
$1,432,518,000.00
$49,590,000.00
Revenue This Year
$2.06
$34.37
Revenue Next Year
$1.64
$22.86
P/E Ratio
$7.05
N/A
Revenue Growth
7.94
142.67
52 Week Low
$16.53
$5.25
52 Week High
$20.80
$10.08

Technical Indicators

Market Signals
Indicator
SPH
XERS
Relative Strength Index (RSI) 44.18 59.95
Support Level $17.10 $6.98
Resistance Level $18.76 $9.01
Average True Range (ATR) 0.44 0.35
MACD -0.06 0.03
Stochastic Oscillator 30.17 94.66

Price Performance

Historical Comparison
SPH
XERS

About SPH Suburban Propane Partners L.P.

Suburban Propane Partners LP distributes propane, renewable propane, renewable natural gas (RNG), fuel oil, refined fuels, and markets natural gas and electricity in deregulated markets. It produces and invests in low-carbon fuel alternatives. The company installs and services home comfort heating and ventilation equipment and distributes fuel oil, kerosene, diesel, and gasoline to about 25,000 residential and commercial customers mainly in the U.S. northeast. It operates three segments: Propane, Fuel Oil and Refined Fuels, and Natural Gas and Electricity, with the Propane segment generating the majority of revenue. Propane, a by-product of natural gas processing and petroleum refining, is a clean-burning energy source known for transportability and ease of use.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

Share on Social Networks: